Photocure ASA
PHO.OLDrugs in Pipeline
10
Phase 3 Programs
3
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 1 past
No catalysts found.
Hexaminolevulinate Hydrochloride
Bladder Cancer
hexaminolevulinate
Bladder Cancer
Hexvix
Bladder Cancer
MAL
Acne
HAL 5% with illumination
Cervical Intraepithelial Neoplasia
Methyl aminolevulinate (MAL) PDT
Acne Vulgaris
Visonac PDT
Acne Vulgaris
methyl aminolevulinate (MAL) and hexaminolevulinate (HAL)
Cervical Dysplasia
Visonac PDT (MAL PDT)
Acne Vulgaris
Area cleaned with Ethyl alcohol solution
Acne Vulgaris
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Hexaminolevulinate Hydrochloride | Phase 3 | Bladder Cancer | - | - |
hexaminolevulinate | Phase 3 | Bladder Cancer | - | - |
Hexvix | Phase 3 | Bladder Cancer | - | - |
MAL | Phase 2 | Acne | - | - |
HAL 5% with illumination | Phase 2 | Cervical Intraepithelial Neoplasia | - | - |
Methyl aminolevulinate (MAL) PDT | Phase 2 | Acne Vulgaris | - | - |
Visonac PDT | Phase 2 | Acne Vulgaris | - | - |
methyl aminolevulinate (MAL) and hexaminolevulinate (HAL) | Phase 2 | Cervical Dysplasia | - | - |
Visonac PDT (MAL PDT) | Phase 2 | Acne Vulgaris | - | - |
Area cleaned with Ethyl alcohol solution | Phase 2 | Acne Vulgaris | - | - |
Frequently asked questions
What is in Photocure ASA's drug pipeline?→
CatalystAlert tracks 10 drug candidates in Photocure ASA's (PHO.OL) pipeline across Phase 3, Phase 2. Its lead program is Hexaminolevulinate Hydrochloride (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Photocure ASA's next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Photocure ASA (PHO.OL) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track PHO.OL biotech catalysts?→
Add PHO.OL to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Photocure ASA's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.